埃莱克萨卡夫托/特萨卡夫托/伊瓦卡夫托在囊性纤维化中纠正盐浪费
Peder Berg1, Amalie Quist Rousing1, Søren Jensen-Fangel2
1Department of Biomedicine, Aarhus University, Aarhus, Denmark.
概括
在囊性纤维化中使用elexacaftor/tezacaftor/ivacaftor (ETI) 治疗可以改善盐和液体平衡,减少盐补充的需要. 这种CFTR调节器疗法可能会增加心血管疾病的风险,需要更新患者指导.
科学领域:
- 心血管医学 心血管医学
- 肺部病理学 肺部病理学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 囊性纤维化 (pwCF) 患者因盐损失而面临液体/电解质失衡,需要增加盐的摄入量.
- 然而,pwCF具有更高的心血管疾病风险,造成了治疗困境.
- 了解CFTR调节器对恒温的作用对于基于证据的指导至关重要.
研究的目的:
- 评估Elexacaftor/tezacaftor/ivacaftor (ETI) 对pwCF中的液体和电解质平衡的影响.
- 在ETI治疗期间评估血压,电解质和荷尔蒙反应的变化.
主要方法:
- ETI对血压,电解质和酸平衡的量化影响.
- 对口服NaHCO3和体积负荷的测量阿尔多素水平和尿液/尿液反应.
- 研究了50个pwCF开始ETI治疗.
主要成果:
- ETI治疗增加了血压,血Na +,以及对NaHCO3 /体积负载的利尿反应.
- ETI降低了心率,阿尔多素水平,以及静脉总CO2.
- 降低了pwCF与低血Na+的比例.
结论:
- 在pwCF中,ETI处理增强了NaCl和液体的保存.
- 应考虑在ETI启动后增加心血管疾病风险.
- 在ETI治疗的pwCF中,可能不需要补充盐.
相关概念视频
Cystic Fibrosis: Management
447
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
447
Cystic Fibrosis: Pathogenesis
680
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
680
Drugs for Treatment of Constipation-Predominant IBS
680
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
680
Drugs for Treatment of Diarrhea-Predominant IBS
599
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
599
Disorder of Water Balance
2.3K
Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
2.3K
Renal Tubule and Collecting Duct
3.0K
The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
3.0K


